Stay updated on Inhaled GB002 for PAH: Phase III Clinical Trial

Sign up to get notified when there's something new on the Inhaled GB002 for PAH: Phase III Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Inhaled GB002 for PAH: Phase III Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision history was updated to include v3.5.2 and remove v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T11:05:31.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added and Revision v3.4.3 was removed from the Record History.
    Difference
    0.1%
    Check dated 2026-03-18T19:43:29.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed from the version history.
    Difference
    0.1%
    Check dated 2026-03-11T17:15:59.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the page history. The older funding notice and the Revision: v3.4.1 entry were removed.
    Difference
    0.6%
    Check dated 2026-02-11T01:54:36.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1 and a government funding notice. Removed Revision: v3.4.0.
    Difference
    0.7%
    Check dated 2026-02-04T00:48:26.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The page now shows a glossary toggle, color-code explanation of changes, and revision labels updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2026-01-27T23:18:38.000Z thumbnail image

Stay in the know with updates to Inhaled GB002 for PAH: Phase III Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Inhaled GB002 for PAH: Phase III Clinical Trial page.